Santhera Pharmaceuticals Holding AG of Switzerland has completed an all-share acquisition of Oy Juvantia Pharma Ltd of Finland thereby giving it control of a compound for the treatment of dyskinesia in Parkinson’s disease. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
